# High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

> **NCT01976195** · PHASE2 · WITHDRAWN · sponsor: **Shandong University**

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT01976195
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-10
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible patient was enrolled.
- **Last updated:** 2016-04-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01976195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01976195, "High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01976195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*